Welcome to the Winter 2019 edition of the European Journal of Arrhythmia & Electrophysiology. We hope you enjoy this issue, which includes a selection of excellent reviews on a range of topics.
Our issue is opened by a foreword from our new editorial board member, Dr Shouvik Haldar. This is followed by a review on the current evidence in His bundle pacing (Burri). Kishor et al. discuss the topic of cardiovigilance in the treatment of atrial fibrillation, and the concept of ‘primordial’ and ‘quinary’ prevention intervention. Ahluwalia and Schilling discuss whether the safe withdrawal of anticoagulation after atrial fibrillation catheter ablation is supported by the data, and finally Scrocco et al. discuss the role of medical therapy in idiopathic ventricular fibrillation.
We welcome colleagues in the field to submit their work to our next edition in summer 2020 – please visit our submission page for more details.
Foreword – European Journal of Arrhythmia & Electrophysiology. 2019;5(2):70
Welcome to the winter 2019 edition of the European Journal of Arrhythmia & Electrophysiology, which is my first edition as a member of the Editorial Board for this excellent free-to-access publication. This issue shines with an amazing array of articles which we are sure you will enjoy reading. All the key bases in arrhythmia and […]
His Bundle Pacing – Why Should You be Doing it?
It is well established that chronic right ventricular apical pacing may have an adverse effect on left ventricular systolic function,1,2 leading, in the long term, to adverse clinical outcomes such as heart failure,3 atrial fibrillation4,5 and even death.6 As an alternative to right ventricular apical pacing, the interventricular septum or right ventricular outflow tract have […]
Cardiovigilance in Atrial Fibrillation – Primordial to Quinary Prevention Intervention
Long-term follow-up of patients with atrial fibrillation (AF) has confirmed a significant increase in cardiovascular events, long-term risk of stroke, heart failure and all-cause mortality (89% in those with AF compared to 27% in those without AF).1 Not only is AF associated with a five-fold increased risk of stroke, AF-related stroke is also likely to […]
Are There Enough Data to Safely Withdraw Anticoagulation After Atrial Fibrillation Catheter Ablation?
The global disease burden of atrial fibrillation (AF) is considerable, and a significant proportion is attributable to the associated thromboembolic risk. The pro-thrombotic environment resulting from AF accrues a five-fold increase in stroke risk, with the arrhythmia implicated in 30% of all strokes.1,2 Evaluating thromboembolic risk should be a primary concern for any healthcare practitioner […]
The Role of Medical Therapy in Idiopathic Ventricular Fibrillation
A survivor of cardiac arrest due to ventricular fibrillation (VF), without a cardiac, respiratory, metabolic, or toxicological explanation, is diagnosed with idiopathic VF.1 Idiopathic VF is estimated to account for approximately 5–7% of all out-of-hospital cardiac arrest cases.2,3 Furthermore, the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER) showed that 44% of out-of-hospital cardiac […]